During the past decade, Rochester Cardiopulmonary Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Cardiopulmonary Group" #1 collaborator was "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Rochester Cardiopulmonary Group" are "Arrhythmia" (1 trials), "Chronic Total Occlusion of Coronary Artery" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Artery Stenosis" (1 trials) and "Coronary Disease" (1 trials). Many other conditions were trialed in "Rochester Cardiopulmonary Group" in a lesser frequency.

Most popular intervention types in "Rochester Cardiopulmonary Group" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azimilide Dihydrochloride" (1 trials), "XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)" (1 trials), "clopidogrel + aspirin OR prasugrel + aspirin" (1 trials), "placebo" (1 trials) and "placebo + aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rochester Cardiopulmonary Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rochester Cardiopulmonary Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rochester Cardiopulmonary Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rochester Cardiopulmonary Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".